CHRONIC HEMODYNAMIC-EFFECTS OF CARVEDILOL IN ESSENTIAL-HYPERTENSION AT REST AND DURING EXERCISE

被引:11
|
作者
LUNDJOHANSEN, P
OMVIK, P
机构
[1] Section of Cardiology, Medical Department, University of Bergen, School of Medicine, Haukeland Hospital
关键词
HYPERTENSION; HEMODYNAMICS; CARDIAC OUTPUT; EXERCISE; BETA-BLOCKERS; CARVEDILOL;
D O I
10.1093/oxfordjournals.eurheartj.a060160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nineteen men (mean age 44 years) with essential hypertension, WHO stage I, were studied invasively at rest and during exercise. Blood pressure was recorded in intra-arterially (brachial artery), cardiac output by dye dilution method and heart rate by electrocardiography. After initial pre-drug recordings, the patients received 25 mg carvedilol orally and central haemodynamics at rest and during exercise were recorded 1 and 2 h after tablet in take to evaluate the immediate effects of curvedilol. The results indicated a combined β-blocking and vasodilating effect. After 6-9 months of treatment, supine haemodynamics were recorded 12-24 h after the last dose and then 1 and 2 h after an additional 25 mg dose. During chronic treatment (2 h after last dose at rest supine) mean arterial pressure was reduced by 17% (P <0.001) and total peripheral resistance index by 6% (NS) while heart rate and cardiac index were reduced by 12%. Exercise haemodynamics demonstratedafall in bloodpressure of 17% (P <0.001). Exercise stroke index increased by 5% (NS), partly compensatingfor the reduction in heart rate of 17%. Total peripheral resistance index was reduced by 5% (NS). It is concluded that carvedilol is an effective anti-hypertensive agent in a large proportion of patients with essential hypertension. The haemodynamic mode of action reflects an a1-blocking activity, particularly in situations with low sympathetic tone. During exercise the β1-blocking activity (demonstrated by the reduction in heart rate) is more prominent. © 1992 The European Society of Cardiology.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [41] RENAL HEMODYNAMIC-EFFECTS OF KETANSERIN THERAPY IN ESSENTIAL-HYPERTENSION
    RAM, CVS
    GONZALEZ, DG
    KAPLAN, NM
    RALAKIS, JM
    HENDERSON, JD
    LUGO, CE
    ZACHARIAH, N
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 : S78 - S80
  • [42] HEMODYNAMIC-EFFECTS OF PINACIDIL AND HYDRALAZINE IN UNTREATED ESSENTIAL-HYPERTENSION
    CARLSEN, J
    LUND, JO
    TRAPJENSEN, J
    ACTA PHYSIOLOGICA SCANDINAVICA, 1982, : 42 - 42
  • [43] ACUTE HEMODYNAMIC-EFFECTS OF PINACIDIL AND HYDRALAZINE IN ESSENTIAL-HYPERTENSION
    CARLSEN, JE
    KARDEL, T
    LUND, JO
    MCNAIR, A
    TRAPJENSEN, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) : 253 - 259
  • [44] NATRIURETIC AND RENAL HEMODYNAMIC-EFFECTS OF NICARDIPINE IN ESSENTIAL-HYPERTENSION
    CHAIGNON, M
    BELLET, M
    LUCSKO, M
    RAPOUD, C
    GUEDON, J
    KIDNEY INTERNATIONAL, 1988, 34 : S184 - S186
  • [45] CARDIAC AND HEMODYNAMIC-EFFECTS OF VERAPAMIL THERAPY IN ESSENTIAL-HYPERTENSION
    FLETCHER, PJ
    HORVATH, JS
    BAILEY, BP
    TILLER, D
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (04): : 571 - 571
  • [46] RENAL HEMODYNAMIC-EFFECTS OF KETANSERIN THERAPY IN ESSENTIAL-HYPERTENSION
    RAM, CVS
    GONZALEZ, D
    LUGO, C
    KAPLAN, NM
    RALAKIS, J
    HENDERSON, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (07): : 542 - 542
  • [47] GUANFACINE IN ESSENTIAL-HYPERTENSION - EFFECTS DURING REST AND ISOMETRIC-EXERCISE
    HEDNER, T
    NYBERG, G
    MELLSTRAND, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (05) : 604 - 609
  • [48] HEMODYNAMIC-EFFECTS OF NIFEDIPINE AT REST AND DURING EXERCISE IN PRIMARY PULMONARY-HYPERTENSION
    OLIVARI, MT
    LEVINE, TB
    WEIR, EK
    COHN, JN
    CHEST, 1984, 86 (01) : 14 - 19
  • [49] METABOLIC AND HEMODYNAMIC-EFFECTS OF ORAL CALCIUM THERAPY IN ESSENTIAL-HYPERTENSION
    GOMEZFERNANDEZ, P
    PEREZMIJARES, R
    RAMOS, M
    BENAVIDES, B
    ALMARAZ, M
    VARGAS, JC
    CASTRO, A
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1598 - 1598
  • [50] RENAL HEMODYNAMIC-EFFECTS OF VASODILATOR THERAPY FOR ESSENTIAL-HYPERTENSION (EH)
    ABRAHAM, PA
    HALSTENSON, CE
    MATZKE, GR
    KEANE, WF
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 175 - 175